Science 37 has unveiled a new patient relationship management and contact centre technology that aims to enhance patient engagement, thereby expediting recruitment and improving enrolment conversion rates.

With the help of this platform, media planning, reporting, placement, and participant communications can be carried out with substantial efficiency to obtain quicker and enhanced patient recruitment into clinical trials.

The platform can also aid in curating content which can be used to boost engagement amongst the current patient community of the company.

On showing interest in a trial, the new contact centre technology provides near and real-time dialogue, across various channels of communication, between an eligible patient and a remote trial coordinator.

This approach aids in guaranteeing that the eligible patients willing to take part have every opportunity to enrol into the trial.

Science 37 chief delivery officer Darcy Forman said: “Our new investments in patient relationship management and contact centre technology enables us to significantly improve the speed and cost to recruit patients, in addition to our conversion rates from contact to consent.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

“While study sponsors often deploy multi-channel approaches to drive patients from outside an investigator’s practice into brick-and-mortar sites, traditional sites have a poor track record in enrolling these referrals into the study because the site’s lack the focus and processes to be successful.

“The Science 37 enrolment model is fully designed with the mindset that no patient should be left behind.”

Participant enrolment in clinical research is the key driver for delays in clinical trials, representing nearly 80% of all trials.